Rhitu Chatterjee
Rhitu Chatterjee is a health correspondent with NPR, with a focus on mental health. In addition to reporting on the latest developments in psychology and psychiatry, she explores the underlying causes of mental health disorders—the complex web of biological, socio-economic, and cultural factors that influence how mental health problems manifest themselves in different groups—and how our society deals with the mentally ill. Chatterjee has a particular interest in mental health problems faced by the most vulnerable, especially pregnant women and children, as well as racial minorities and undocumented immigrants. She has reported on chronic stress from racism's devastating impact on pregnancy outcomes in black women, the factors that put adolescents and youth on a path to school shootings, and what some schools are doing to keep them off that path. Chatterjee has covered the rising rates of methamphetamine and opioid use by pregnant women, and how some cities are helping these women stay off the drugs, have healthy pregnancies, and raise their babies on their own. She has also written about the widespread levels of loneliness and lack of social connection in America and its consequences on people's physical health. Before starting at NPR's health desk in 2018, Chatterjee was an editor for NPR's The Salt, where she edited stories about food, culture, nutrition, and agriculture. In that role, she also produced a short online food video series called “Hot Pot: A Dish, A Memory”. The series was produced in collaboration with NPR's Goats & Soda blog. Prior to that, Chatterjee reported on current affairs from New Delhi for PRI's The World, and covered science and health news for Science Magazine. She has covered the legacy of the Bhopal gas tragedy in 1984, the world's largest industrial disaster. She has reported on a mysterious epidemic of chronic kidney disease in Sri Lanka and India. While in New Delhi, she also covered women's issues. Her reporting went beyond the breaking news headlines about sexual violence to document the underlying social pressures faced by Indian girls and women. Throughout her career, Chatterjee has reported on everything from basic scientific discoveries to issues at the intersection of science, society, and culture. She has won two reporting grants from the Pulitzer Center on Crisis Reporting and was awarded a certificate of merit by the Gabriel Awards in 2014. Chatterjee has mentored student fellows by the Pulitzer Center on Crisis Reporting, as well as young journalists for the Society of Environmental Journalists’ mentorship program. She has also taught science writing at the Santa Fe Science Writing Workshop.
70%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
0%
Examples:
No current examples available.
Conflicts of Interest
100%
Examples:
No current examples available.
Contradictions
95%
Examples:
- Marijuana is currently classified as a Schedule I controlled substance, which is defined as a substance with no accepted medical use and a high potential for abuse.
- Reclassifying the drug as Schedule III puts it in the same category as ketamine and Tylenol with codeine. Substances in this category have accepted medical use in the United States, have less potential for abuse than in higher categories and abuse could lead to low to moderate levels of dependence on the drug.
- The current Schedule I status imposes many regulations and restrictions on scientists’ ability to study weed.
Deceptions
100%
Examples:
No current examples available.
Recent Articles
Biden Administration Announces Plans to Reschedule Cannabis: From Schedule I to III
Broke On: Friday, 03 May 2024The Biden administration announced plans to loosen federal cannabis restrictions, moving marijuana from schedule I to schedule III on the Controlled Substances Act. This decision follows a review by the Department of Health and Human Services concluding that marijuana has medical benefits and potential for abuse. The change could support Biden among young voters, ease research, and grow the legal cannabis industry projected to reach $70 billion by 2030. However, public comment period and lawsuits are expected.